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ABSTRACT 
In order the drug bioavailable in human body must absorb it, and in oral treatments absorption takes place, after drug dissolution by diffusion 
of the molecules through gastrointestinal   membranes. It was found that BCS class –II drug has poor aqueous solubility in GI tract greatly 
influences the drug release; particularly it affects the bioavailability of drug. Solubilization of water insoluble drug is a big issue of 
pharmaceutical research. Nanohybrids are combination of two or more different materials with different properties of each and that are fused, 
by an effort to blend the best properties of both. In nanohybrids there is use of natural and synthetic polymers. The present review mainly 
focusing on the simple and convenient method of preparation of nanohybrids with the help of Microwave irradiation Method by using 
natural/synthetic carriers such as acacia, gelatin, cassia, ghatti gum, and HPMC, MC etc. to enhance the solubility of poorly  water soluble BCS 
Class –II Drugs and improved its rate of dissolution for such drug entities which affects the bioavailability. Prepared nanohybrids can be 
characterized by Scanning Electron Microscopy, Fourier transform infrared spectroscopy, Differential Scanning Calorimetry, X-Ray Diffraction 
Studies and transmission Electron Microscopy. Further, this review mainly highlights the application and future prospective u se of 
nanohybrids, which will help in formulation of drug with improved bioavailability. 
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1. INTRODUCTION 
The oral route is the major way of dosing both existing and 
new drugs. Most of the drugs which administrated by oral 
route are absorbed by passive diffusion through the gastro-
intestinal (GI) cellular membranes. The solubility and 
permeability are the most important tools for determining 
the oral bioavailability of specific drugs within the GI tract, 
which have aqueous environment. According to US 
pharmacopoeia more than 40% of the drugs are poorly 
soluble or insoluble in aqueous environments.[1] The 
enhancement oral bioavailability of poorly water-soluble 
drugs represent an actual challenge for pharmaceutical 
research, with the aims of improving drug therapeutic 
effectiveness as well as creating new market opportunities. 
The BCS class II drugs are water-insoluble (solubility equal 
or less than 100 µg of solute per 1 ml of solvent) but have 
high membrane permeability is only limited by dissolution. 
The energy-driven step is dissolution of crystalline solid in a 
process. In general, the kinetics of the process depends on 
solute, solvent chemical nature, microstructure and on the 
system conditions. It is possible to show that the dissolution 
rate of a crystalline drug in a given dissolution environment 
can be increased by forcing it to assume a microstructure by 
the theories of dissolution and non-electrolytes solubility 
characterized in nanoscale (short range) periodicity. The 
latest and most effective approaches to water-insoluble 
drugs solubilization are based on generating a drug 
dispersion (at molecular and/or nanoscale level) in a 
stabilizing media, preferably in solid-state form. Our main 
approach is that the enhancing effects of Microwave (MW) 
heating on mass transport might provide a green, effective 
instrument for generating such dispersions. 
 Nanohybrids are combination of two or more different 
materials with different properties of each and that are 
fused, by an effort to blend the best properties of both. A 
hybrid is consists of two materials of varying natures and 
combination of those shows improved in their properties 
greater than that of individual. The melting or fusion 
technique is one of the simple and efficient technique in the 
preparation of nanohybids or/and bionanocomposites for 
the solubility and dissolution enhancement. Particle size 
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reduction provides more surface area for absorption and 
rapid dissolution. Microwave radiation consists of 
electromagnetic waves with frequencies between the 
infrared and radio waves, which is in the range of 0.3–300 
GHz.It passes through materials and oscillate their 
molecules, which generating heat. The ability of microwave 
to penetrate any substance, which produced the heating a 
sample at any point at a given time .The first and unique 
attempt was proposed by Kerk et al in the direction of 
bioavailability enhancement. The pharmaceutical 
nanocomposites which prepared by MW processing which 
was silicon dioxide substrate with isolated molecular 
clusters which adsorbed on the surface. Nevertheless, it 
seems that re-crystallization is not definitively inhibited, as 
drug molecules have high mobility on inorganic surfaces. 
These approach consisting the replacement of inorganic 
surface with inert 3D-matrixes that having the suitable 
microstructure properties to prevent re-crystallization of the 
drug. The cross-linked polyvinylpirrolidone (Crospovidone) 
is first chosen matrix which constrains the drug into stable 
molecular clusters and/or nanocrystals by its 3D network. 
The other matrix like cyclodextrin, is a torus-shaped 
molecule that forms molecular complexes with the drug. 2 
2. Biopharmaceutical classification system 3,4 
Class I - High Permeability, High Solubility: 
These drugs are having high absorption number and high 
dissolution number. The rate limiting step is drug dissolution 
and if dissolution is very rapid then gastric emptying rate 
becomes the rate limiting step. e.g. metoprolol 
Class II – High Permeability, Low Solubility:  
These drugs have a high absorption number and a low 
dissolution number. In vivo drug dissolution is then a rate 
limiting step for absorption except at a very high dose 
number. These drug exhibit changeable bioavailability and 
need the improvement in dissolution for increasing the 
bioavailability. These compounds are suitable for design the 
SR and CR formulations. In vitro- in vivo correlation (IVIVC) 
is usually projected for class II drugs.  
e.g. Phenytoin 
Class III- High Solubility, Low Permeability: 
Permeation throughout the intestinal membrane is the rate-
determining step for these drugs. as absorption is 
permeation rate limited, bioavailability is independent of 
drug release from the dosage form. These drugs generally 
show low bioavailability and permeability enhancement is 
generally essential. These drugs are challenging for 
controlled release development. e.g.Cimitidine 
Class IV- Low Solubility, Low Permeability: 
Drugs of this class show poor and unpredictable 
bioavailability. The overall bioavailability is govern by 
several factors such as rate of dissolution, intestinal 
permeability, gastric emptying, and so on. These drugs are 
generally not appropriate for oral drug delivery or moreover 
some special drug delivery technologies such as 
nanosuspensions will be needed 
 
Thus, from the BCS, most of the drugs go to class II shows 
poor solubility in aqueous medium with high membrane 
permeability. Since, the dissolution of drugs will be the rate-
limiting step in drug absorption from the oral solid dosage 
forms of this class. Due to poor solubility of drugs belongs to 
class-II category in aqueous medium is big challenge and this 
overwhelm can be solved by using various solubility 
enhancement techniques, one of the most formidable aspects 
of drug development. A significant description of the 
solubilisation and delivery of insoluble drugs can be found in 
Liu’s monograph.  The Noyes–Whitney equation shows 
factors in dissolution rate with surface area. The Ostwald–
Freundlich and Kelvin equations demonstrate that this no 
longer applies below a particle diameter of approximately 1 
mm, remarkably less than 0.1 mm, where the extreme 
curvature of the particles leads to an increase in dissolution 
pressure and hence solubility . A particle size reduction 
technique leads to an increase in surface area and dissolution 
rate. Nanonization has been used to get a particle size 
between 100 nm -1000 nm. 
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3. Technique for solubility enhancement: 5, 6, 7 
1] Physical Modifications.  
Particle size reduction like micronization and 
nanosuspension, alteration in the crystal habit like 
polymorphs, amorphous form and co crystallization, drug 
dispersion in carrier like eutectic mixtures, solid 
dispersions, solid solutions and cryogenic technique. 
 2] Chemical Modifications.   
Adjust of ph; make use of of buffer, derivatization, 
complexation, and salt formation.  
3] Miscellaneous Methods.  
Supercritical  fluid process, use of adjuvant like surfactant, 
solubilizers, cosolvency, hydrotrophy, and novel excipients. 
The technology used to describe the term as ‘solubility 
enhancing’ can be misleading, since although the 
phenomenon of super-saturation is true, the techniques 
used do not increase the solubility of insoluble compounds. 
More accurately, they present the drug in a form which is 
optimal to its absorption, given its solubility limitations. It is 
also important to be aware that water solubility also 
requires the specification of temperature and pH; under 
certain physiological conditions many important drugs only 
show aqueous solubility, and reach to the site of absorption.  
3.Mechanism of solubilisation :8 ,9,10 
The process of solubilisation involves the 
1] Breaking of inter-ionic or intermolecular bonds in the 
solute 
2] The separation of the molecules of the solvent to provide 
space in the solvent for the solute 
3] Interaction between the solvent and the solute molecule 
or ion. 
4. Nanohybrids: 
Nanohybrids are combination of two or more different 
materials with different properties of each and that are 
fused, by an effort to blend the best properties of both.  
Hybrids are   consists of two materials of varying natures 
and combination of those shows improved in their 
properties greater than that of individual. A physical mixture 
of drug and Natural / bio and synthetic carrier in the hybrid 
by nanotechnology and their evaluating parameters as drug 
release profile by in-vivo and in -vitro and bioavailability in 
biological system hence termed nanohybrids.12,13 
4.1 Classification of nanocomposites: 11 
Nanohybrids are subtypes of polymer based 
nanocomposites  
[Inorganic/Organic polymer nanocomposites] 
A] Polymer based nanocomposite: 
 Polymer/ceramic nanocomposite 
 Inorganic/ Organic hybrid  nanocomposites  
Polymer/ Layered silicate Nanocomposites  
Polymer/polymer Nanocomposites  
Biocomposites/ bionanocomposite 
B] Non polymer based nanocomposite: 
 Metal/Metal Nanocomposite 
 Metal/Ceramic nanocomposites  
Ceramic/Ceramic Nanocomposites 
Inorganic / Organic hybrid nanocomposites: 
 Hybrid inorganic/organic materials are not just physical 
mixtures; they can be broadly defined as nanocomposites 
with organic and inorganic components thoroughly mix. 
Indeed, hybrids are either homogenous system derived from 
monomers and miscible organic/inorganic components, or 
heterogenous systems (nanocomposites) where at least one 
of the components has the scale of nanometer.  
4.2 Method used for solubility enhancement/ 
preparation of nanocomposites 14: 
A) Solution intercalation  
In this system, the bio-polymer or bio-prepolymer, such as 
starch and protein is added into the solvent which is 
completely soluble in solvent. The inorganic nano fillers such 
as silicate platelets are swollen in a solvent such as water, 
chloroform or toluene. When the biopolymer and solution of 
swollen nanoparticles are mix, the polymer chains 
intercalate and move the solvent within the interlayer of the 
silicate. Upon solvent exclusion the intercalated structure 
remnants, resulting in a creation of biopolymer/ layered 
silicate bio-nanocomposite. 
 B) In situ intercalative polymerization 
In this method, the nanoparticle is discrete in a liquid 
monomer or a monomer solution, so the polymer 
development can occur between the intercalated sheets. 
Polymerization can be completed either by heat or radiation, 
by the diffusion of a suitable initiator, or by an organic 
initiator or catalyst.  
 C) Melt intercalation  
The melt intercalation technique has become the ordinary 
method for the preparation of polymer/layered silicate bio-
nanocomposites. There are lots of advantages compare with 
solution intercalation and in situ intercalative 
polymerization. In this process, the polymer is heated at 
specific temperature to obtain a molten mass and mixed 
with nanoparticle. It can be done by the extruder.  
D) Template synthesis 
In this method, biomolecules, parts and whole cells, 
microorganisms offer as the template for inorganics which 
are generate from a precursor. The templating bio organics 
is in nanosized particle which is entrapped in mesoporous 
matrix. This technique is highly adaptable. This is a simple 
and easy procedure and relevant for large scale production. 
This method mostly required water soluble polymers and 
the resulting product may be probability of contagion due to 
side product . 
4.3 Microwave assisted synthesis 15, 17 
The electromagnetic irradiation spectrum of Microwave 
irradiation (0.3–300 GHz) is lies between the IR and radio 
frequencies with correspond to wavelengths of 1 cm - 1 m. 
Microwave techniques were useful technique into the 
pharmaceutical field for various approaches like as tablets, 
agglomerates, formation of gel beads, nanomatrix, 
microspheres, film coats, and solid dispersions. 
 Microwave frequency:  
Microwave heating refers the make use of of electromagnetic 
waves ranges from 0.01m to 1m wave length of definite 
frequency to create heat in the material. These microwaves 
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lie in the region of the electromagnetic spectrum between 
mm wave and radio wave i.e. between IR and radio wave and 
they are defined as those waves with wavelengths between 
0.01m to 1m, corresponding to frequency of 30GHz to 
0.3GHz.  
Microwaves can be directly transformed into heat within the 
material. Therefore, it is capable to achieve uniform and 
rapid heating even in materials with low heat conductivity, 
such as polymers, because the transfer of energy does not 
depend on heat diffusion. This is very significant in the 
preparation of drug formulations because many excipients 
are polymers. This mechanism is employed extensively for 
making drug– polymer interaction, polymeric cross linkages 
as well as structural modification of drug crystals via its 
effects of heating.  
The technique offers simple, fast, economic, and efficient. 
Recently microwave assisted synthesis has emerged as new 
tool in particle size reduction and dissolution enhancement. 
Due to its capacity to couple directly with the reaction 
molecule and by passing thermal conductivity leading to a 
fast rise in the temperature, microwave irradiation has been 
used to progress many organic syntheses. 
The basic principle behind the heating in microwave oven is 
due to the interaction of charged particle of the reaction 
material with electromagnetic wavelength of particular 
frequency. The phenomena of producing heat by 
electromagnetic irradiation are ether by collision or by 
conduction, sometime by both. All the wave energy changes 
its polarity from positive to negative with each cycle of the 
wave. This cause rapid orientation and reorientation of 
molecule, which cause heating by collision. 
 Reaction mixture heating proceeds directly inside mixture. 
No need of physical contact of reaction with the higher 
temperature source. 
Heating take place by electromagnetic wave 
Heating mechanism - dielectric polarization & conduction 
Heating to Specific component can be possible. 
Heating rate is several folds high. 
4.4 Advantages of microwave assisted synthesis: 
Rapid volumetric heating  
No overheating at the surface  
Energy savings and Addressable heating  
Higher yields and shorter preparation times  
Lower operating costs 
Small Narrow particle size distribution  
High Purity 
4.5 Mechanism of microwave assisted synthesis: 16 
A) Heating Mechanism:  
The mixture may be treated with high frequency 
electromagnetic waves. The heating starts from the 
interaction of electric field of the wave and charged particle 
in the mixture. Two basic principle mechanisms involve in 
the heating of mixture of drug and natural / bio carrier. 
B) Dipolar Polarisation:  
Dipolar polarisation is a technique by which heat is 
generated between polar molecules. On exposure to the high 
electromagnetic field of appropriate frequency, polar 
molecules try to follow the field and orient themselves in 
phase with the field. The random motion of particles and 
random interaction generate heat. Microwave radiation has 
the proper frequency (0.3-30 GHz) to oscillate polar 
particles and allow enough inter-particle interaction.  
C) Interfacial Polarization: 
 This mechanism is important for system where a dielectric 
material is not homogenous, but consists of conducting 
inclusion of one dielectric in other.  
D) Conduction Mechanism:  
The mechanism generates heat through resistance to an 
electric current. The oscillating electromagnetic field 
produces an oscillation of electrons or ions in a conductor, 
resulting in an electric current. This current faces internal 
resistance, which heats the conductor.  
4.6 Use of natural/synthetic polymers in nanohybrids : 
18,19 
Biopolymers have used as drug carrier substrates in the past 
with several studies examining materials, such as sodium 
alginate, chitosan and gelatin results into formation of 
threedimensional (3D) structure. Carbohydrate polymers 
are widely used in recent years in pharmaceutical and 
biomedical applications due to their biocompatibility and 
biodegradability. The polysaccharides characterize one of 
the most abundant industrial raw materials and have been 
the topic of thorough research due to their sustainability, 
biodegradability and bio-safety. Different types of natural–
origin carriers, especially proteins and polysaccharides (the 
systems more inspired on the extracellular matrix) that are 
being used in research, or might be potentially useful as 
carriers systems for active API as well as biomolecules with 
application in the solubility enhancement field and targeting 
several biological tissues. The combination of both 
applications into a single   material has proven to be very 
challenging though. The earliest exclusive approach towards 
formation of nanocomposites was done by Kerc et. al. used 
silicon dioxide as the substrate for adsorption of drug, 
however, recrystallization of the drug was encountered as 
major problem due to the high mobility of drug molecules on 
inorganic surfaces. Replacement of the inorganic surface 
with inert 3D matrixes (cyclodextrin and crospovidone), that 
possess suitable microstructural properties for preventing 
recrystallization of the drug. The use of natural carriers in 
solubility and dissolution enhancement is a pioneering 
concept. Use of natural carriers as a composite material for 
incorporating drug in the nanocrystalline form with the help 
of microwave-induced diffusion (MIND), which is a green 
and effective way of generating nanocomposites. The 
carriers for BNCs are gelatin, acacia gum, cassia gum and 
ghatti gum or some other reported polymer. These carriers 
are selected on the basis of their wetting and good surfactant 
properties, which additionally support the enhancement of 
solubility and dissolution and ultimately bioavailability. 
Gelatin is a natural protein carrier that has a good dielectric 
property, the remaining carriers are carbohydrates, which 
also have good dielectric properties, indicating excellent 
efficacy of molecular heat transfer required for MIND. 
Synthetic Polymer to be used are HPMC, PVP, MC, 
Polypropylene, Polystyrene etc. because having 
characteristics such as inert, Thermally stable, high tensile 
strength and excellent dielectric properties , chemically inert 
etc. 
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4.7 Characterization Of Polymers: 20,21 
1] Swelling Characteristics: 
 Swelling index (SI) was expressed as a percentage and 
calculated according to the following equation:  
     HF-Hi   
SI =  
                    Hi 
Where, X0 is the initial height of the powder in the 
graduated cylinder and  
Xt denotes the height occupied by swollen gum after 24 
hours .  
2] Viscosity Determination:  
The viscosity of the carrier dispersions is measured by 
viscometer using spindle 3 at 100 rpm  
3] Foaming Index:  
The foaming index of the carrier is measured to establish 
their surfactant properties. The foaming index can be 
calculated by the following equation:  
Foaming index: vf-vi 
Where, Vf is the volume of 1% w/v solution of carrier after 
shaking and Vi is the volume of 1% w/v solution of carrier 
before shaking. 
Preparation of physical mixtures for Nanohybrids:  
A physical mixture of drug with natural carriers prepared by 
simple blending of drug with carrier in required ratios 
(drug: carriers) for 10 min.  
Preparation of Nanohybrids :  
For each sample, a physical mixture of API and 
natural/synthetic  carrier was made by uniform mixing. The 
weight-to-weight (w/w) ratio of drug to the carrier taken as 
per required by ratios keeping amount of mixture constant. 
Then 4 ml of water added for each gram of the drug–carrier 
mixture to make homogeneous slurry (the water added for 
hydration of the carrier). A fixed amount of the slurry (5 gm) 
placed in a glass beaker with a Teflon stirrer (transparent to 
microwaves) and treated with microwave irradiation for 
different times at power of 560 W. The temperature of the 
mixture at the end of treatment recorded using an inbuilt 
temperature measurement probe. The samples then ground 
in a glass mortar and sieved to achieve a particle size of 80–
250 mm.  
4.8 Evaluation of Prepared Nanohybrids: 
A) Drug content analysis: 
 To identify the amount of drug incorporated in the 
Nanohybrids, Drug extracted from the nanohybrids  by 
dissolving them in adequate 25 ml solvent. The 0.2μ 
membrane filter used to filter the resulting solution. The 
drug content in the solvent extracts is analyzed by using UV-
Visible spectrophotometer at its λmax, against the solvent as 
blank.  
B) Solubility study:  
The solubility of drug and physical mixture determined in 
pH 6.8 phosphate buffer. The solubility of drug, physical 
mixtures and nanohybrids determined by taking an excess 
amount of drug (30 mg) and nanohybrids (equivalent to 30 
mg of drug) and adding them to 10 ml of solvent (pH 6.8 
buffer), in Teflon-facing screw-capped vials. The samples 
were kept at equilibrium for a period of 48 h on an orbital 
shaking at 37- 0.5°C and 50 rpm. The supernatant fraction 
collected from the vials was filtered through a 0.2μ 
membrane filter and analyzed by UV-Visible 
spectrophotometer at a λmax. Ratio optimization (drug: 
carrier) done on the basis of the best solubility results 
obtained. 
 C) Powder dissolution test:  
The powder dissolution test performed on nanohybrids  
following the USP XXIV Apparatus 2 (paddle) method in 900 
ml of dissolution media maintained at 37± 0.5°C at. Powder 
containing 5 mg. API was added to dissolution media. All 
experiments were carried out in 3 steps. Dissolution profiles 
of nanohybrids  were compared with that of the pure drug at 
the same experimental conditions.  
D) Drug dissolution kinetics:  
To describe and explain drug dissolution rates, various 
mathematical models were useful. Efficacy of these models 
relies on the nature of the dosage unit. 
4.9 Characterisation of Nanohybrids: 
From the results obtained by solubility and dissolution 
studies, the nanohybrids, which noticed the better results, 
selected for further characterization.  
A) Fourier-transform infrared spectroscopy:  
Fourier-transform infrared (FTIR) spectra of pure API, pure 
carriers and nanohybrids of individual API with individual 
carriers are taken to access interaction, if any, between drug 
and gum in mixtures. Nanohybrids  of drug with each carrier 
mixed with potassium bromide (KBr) of IR grade in a ratio of 
1:100 and compressed using a motorized pellet press at 15 
tonnes pressure. The pellets then scanned using an FTIR 
spectrophotometer. The FTIR spectra of mixtures compared 
with that of the carriers and pure API to assess any change in 
the principal peaks of spectra of pure drug and carrier.  
B) Differential scanning calorimetry:  
Differential scanning calorimetry (DSC) studies of pure drug 
and carriers and nanohybrids  of individual drug with 
individual carriers performed to assess what changes had 
actually occurred when nanohybrids formed and by what 
phenomenon these enhanced drug solubility. Accurately 
weigh the test sample in aluminium pans, approximately 2–4 
mg, based on the drug content in the formulation, and seal. 
An empty aluminium pan used as a reference. DSC 
thermograms obtained by differential scanning calorimeter 
at a heating rate of  10°C/min from 0 to 300°C in nitrogen 
atmosphere.  
C) X-ray diffraction studies:  
X-ray diffraction (XRD) determines the drug and pure 
carriers. The nanocomposites of individual drug with 
individual carriers performed to assess the changes in the 
crystallinity made when the drug mixed with carriers. XRD 
patterns can be helpful to record using Philips magnification 
at an acceleration voltage of 10 kv using a scanning electron 
microscope. diffractometer and Cu-ka radiation (l = 1.5418 
Å), monochromatised by a secondary flat graphite crystal.  
D) Scanning electron microscopy:  
nanohybrids that showed the best results in the solubility 
and dissolution studies subjected to scanning electron 
microscopy (SEM) to investigate to confirm the changes 
made during the formation of BNCs. Samples prepared by 
mounting powder onto a brass stub using graphite glue and 
coated with gold under vacuum before use. Images recorded 
at the required 
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E) Transmission electron microscopy:  
The optimized ratio of nanohybrids showing the best results 
in the solubility and dissolution studies subjected to 
transmission electron microscopy (TEM) studies to confirm 
the formation of nanocrystals embedded in composites. The 
specimens for TEM mounted on a carbon-coated copper grid 
made of disc type with a thinned (electron transparency) 
central area of size 3 mm. The images obtained by using a 
PHILIPS CM200 transmission electron microscope at 
operating voltages 20–200 kv with a resolution of 2.4 A°. 
5. APPLICATION14 
1. The nanocomposite materials are also good candidates for 
catalysts, gas-separation membranes, contact lenses and 
bioactive implant materials. 21   
2. Bionanocomposites are used in fabrication of scaffolds, 
implants, diagnostics and biomedical devices and drug-
delivery systems. It also used in the cosmetics industries.  
 3. Ahemad et al (2017), focused on the medical speciality 
and Cumulative applications of Chitosan centred 
bionanocomposites. He demonstrated the various schemes 
for the preparation of chitosan nanocomposites from 
different functional material, focusing on their application 
specifically in tissue engineering, drug and gene delivery, 
wound healing and bio imaging. 
 4. Selvakumar et al (2015), developed the enriched 
adhesion of talc/ZnO nanocomposites on cotton fabric 
assisted by aloe-vera for bio-medical application mostly 
used on baby diaper. 22  
 5. Sajid et al (2012) synthesized and characterized the silica 
nanocomposites for bone applications. 23  
6. Stodolak et al (2009), studied on nanocomposite fibres 
and find out its medical applications. She successfully 
modified the calcium alginate fibres with the nanofiliers 
which creates an opportunity in tissue regeneration by using 
the fibres as bioactive materials. 24  
7. Tamayo et al (2016), developed the copper polymer 
nanocomposites which is excellent and cost effective biocide 
controllingor inhibiting the growth of microorganisms and 
preventing foodborne diseases and nosocomial infections. 25  
8. Polymer nanocomposites used in gene delivery for 
purpose of aanticancer drug delivery, pDNA transfection, 
siRNA and DOX delivery, CPT drug and report. 26  
 9. It is used as actuators in artificial muscle. 27  
10. Kendre et al (2017), developed the Bosentan 
nanocomposite by using amphiphilic graft co-polymer-
carrier which is soluplus to enhanced the solubility, 
dissolution and bioavailability. He prepared the graft co-
polymer-based nanocomposite formulation by using the 
single-emulsion technique. 28  
11. Kumar et al (2010), prepared and characterized the bio-
nanocomposite films based on soy protein isolate and 
montmorillonite using melt extrusion. These bio-
nanocomposite films could potentially be used for packaging 
of high moisture foods such as fresh fruits and vegetables to 
replace some of the existing plastics such as low density 
polyethylene (LDPE) and polyvinylidene chloride (PVDC).  29  
12. Cherian et al (2011), developed the cellulose 
nanocomposites with the help of nanofibres which is 
isolated by pineapple leaf fibers. The developed composites 
were utilized to fabricate various versatile medical implants. 
Pineapple leaf fibers derived nanocellulose embedded 
polyurethane has beenutilized as an attractive and readily 
available range of materials for the fabrication of vascular 
Prostheses and used for to make heart valves and coronary 
stent in the cardiovascular system. Bionanocomposites 
mostly applicable in development of cardiovascular system. 
30, 31  
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